# RAVGEN, INC.: Form D filings

RAVGEN, INC., a biotechnology company in Columbia, MD, filed 7 Form D notices with the SEC between 2011 and 2021. The latest, on October 27, 2021, reports $2.5 million sold of a $3.5 million offering to 11 investors.

Find out what RAVGEN, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RAVGEN%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RAVGEN%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fravgen-inc-1140834)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RAVGEN%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RAVGEN%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fravgen-inc-1140834)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9241 RUMSEY ROAD, Columbia, MD, 21045
- Phone: (410) 715-2111
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1140834

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 27, 2021 | Amendment | $3,500,000 | $2,481,652 | $1,018,348 | 11 | May 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083421000008/0001140834-21-000008-index.htm) |
| Aug 9, 2021 | Amendment | $3,500,000 | $2,450,000 | $1,050,000 | 8 | May 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083421000007/0001140834-21-000007-index.htm) |
| Jul 27, 2021 | Amendment | $3,500,000 | $2,150,000 | $1,350,000 | 6 | May 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083421000006/0001140834-21-000006-index.htm) |
| Jul 2, 2021 | Amendment | $3,500,000 | $1,900,000 | $1,600,000 | 5 | May 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083421000005/0001140834-21-000005-index.htm) |
| Jun 3, 2021 | New notice | $3,500,000 | $800,000 | $2,700,000 | 3 | May 20, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083421000004/0001140834-21-000004-index.htm) |
| May 14, 2012 | Amendment | Indefinite | $1,091,663 | Indefinite | 15 | Apr 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083412000001/0001140834-12-000001-index.htm) |
| May 13, 2011 | New notice | Indefinite | $884,400 | Indefinite | 11 | Apr 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1140834/000114083411000004/0001140834-11-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kamlesh Dhallan | Director |  |
| Philip Bayliss | Director |  |
| Edward Mottern | Director |  |
| Narender Dhallan | Director |  |
| Ravinder Dhallan | Executive Officer, Director, Promoter |  |

## Other biotechnology companies in Maryland that filed recently

- [BlueHealer Inc.](https://specstream.ai/data/form-d/company/bluehealer-inc-2162934) $1 · Nov 4, 2026
- [Accufy Diagnostics, Inc.](https://specstream.ai/data/form-d/company/accufy-diagnostics-inc-2089723) $2 million · Oct 28, 2026
- [OS Therapies Inc](https://specstream.ai/data/form-d/company/os-therapies-inc-1795091) $7.2 million · Oct 23, 2026
- [Kaigene, Inc.](https://specstream.ai/data/form-d/company/kaigene-inc-1919055) $55 million · Oct 14, 2026
- [Templar Nova, Inc.](https://specstream.ai/data/form-d/company/templar-nova-inc-2158642) $7 million · Oct 7, 2026
- [Monocacy Therapeutics Inc.](https://specstream.ai/data/form-d/company/monocacy-therapeutics-inc-2137361) $25,000 · Oct 7, 2026
- [Seraxis Holdings, Inc.](https://specstream.ai/data/form-d/company/seraxis-holdings-inc-1845486) $10 million · Sep 24, 2026
- [Uvantis Therapeutics, Inc.](https://specstream.ai/data/form-d/company/uvantis-therapeutics-inc-2156954) $100,000 · Sep 23, 2026
- [Gliknik Inc](https://specstream.ai/data/form-d/company/gliknik-inc-1411569) $15 million · Sep 17, 2026
- [Georgiamune, Inc.](https://specstream.ai/data/form-d/company/georgiamune-inc-2148230) $92.7 million · Aug 17, 2026

[Every Form D from the week of Oct 25, 2021](https://specstream.ai/data/form-d/week/2021-10-25) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RAVGEN, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).